Webcast

1-7 of 72 Activities
Title
Availability
Format
Credits
Launch Date
Buttons
Buttons
On-Demand
Webcast
0.75
02/19/2025

Psoriasis Progress: Bridging Knowledge Gaps in Emerging Therapies for Clearer Futures

In this CME Outfitters Snack, expert faculty, including dermatologists, will address the educational needs of dermatology providers and other HCPs including improving their knowledge of the efficacy and safety data for novel and emerging therapies in PsO, discussing clinical experiences, current and late-breaking research, and how to integrate this data into their management of patients with PsO.

0.75
02/19/2025

Susan C. Taylor, MD

Susan C. Taylor, MD

Andrew F. Alexis, MD, MPH

Andrew F. Alexis, MD, MPH

Moderator

Buttons
On-Demand
Webcast
1
02/10/2025

Closing Gaps in Care for Short Bowel Syndrome in the Community Setting

In this CME Outfitters recorded Grand Rounds activity, expert faculty will guide participants through a discussion of the pathophysiology and associated complications of SBS, currently available and emerging SBS treatment strategies promoting enteral autonomy and reducing the need for PN, and how to develop interdisciplinary and interprofessional coordinated care plans for patients with SBS managed in the community setting.

1
02/10/2025

Anne Debra Feldman NP-C

Anne Debra Feldman NP-C

Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, FASPEN, CNSC, CPNS

Donald F. Kirby, MD, FACP, FACN, FACG, AGAF, FASPEN, CNSC, CPNS

Buttons

IBD, IL-23, and Inflammation, Oh My! Following the Yellow Brick Road in Using IL-23 Targeted Therapies in Managing IBD

In this CME Outfitters recorded symposium, expert faculty will instruct learners on the role of pro-inflammatory cytokines in the pathogenesis of IBD. Learners will be guided on the role of the IL-23/Th17 inflammatory axis in IBD pathogenesis and how to appraise the clinical implications of anti-IL-23 agents used in the treatment of IBD. Faculty will model the development of individualized treatment plans for patients with IBD that are eligible for treatment with an IL-23-targeted agent.

1.5
02/10/2025

Uma Mahadevan, MD

Uma Mahadevan, MD

Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN

Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN

Corey A. Siegel, MD, MS

Corey A. Siegel, MD, MS

Moderator

Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE, FCCF

Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE, FCCF

Buttons
Live
Webcast
0.75
03/18/2025 at 4:15 pm EST

Livestream: Pan-Viral Screening for HBV, HCV, and HIV in Diverse Practice Settings

In this CME Outfitters livestream symposium, faculty will discuss the integration of guideline-based universal testing to address screening gaps for HIV, HBV, and HCV; evaluate pan-viral testing strategies that improve engagement in diverse practice settings; and explore strategies to incorporate guideline-recommended pan-viral and perinatal screenings into the care of patients who are pregnant to improve outcomes and limit perinatal transmission.

0.75
03/18/2025 at 4:15 pm EST

Juhi Moon, MD

Juhi Moon, MD

Moderator

Christina M. Madison, PharmD, FCCP, AAHIVP

Christina M. Madison, PharmD, FCCP, AAHIVP

Buttons
Live
Webcast
1
04/05/2025 at 8:00 am EST

Livestream: Initiating Basal Insulin: Moving from Hesitancy to Action

In this CME Outfitters live chapter meeting, expert faculty will discuss important strategies for identifying how to best overcome delays in insulin initiation as well as how to differentiate current and emerging basal insulin therapies and their impact on therapeutic inertia.

1
04/05/2025 at 8:00 am EST

E. Seth Kramer, DO, MPH, Dipl of ABOM

E. Seth Kramer, DO, MPH, Dipl of ABOM

Javier Morales, MD, FACP, FACE

Javier Morales, MD, FACP, FACE

Buttons
On-Demand
Webcast
1
12/27/2024

Deciphering Ulcerative Colitis: Clinical Clues for Treatment Selection, Switching, and Disease Optimization

In this CME Outfitters Infographic, expert faculty will explore the role of new advanced therapies in UC treatment algorithms, facilitating the transition to these therapies in patients with UC who are non-/under-responsive to traditional treatments, and utilizing traditional treatments as well as available biologics and small-molecule therapies to optimize outcomes in patients with IP.

1
12/27/2024

Anita Afzali, MD, MPH, MHCM, FACG, AGAF

Anita Afzali, MD, MPH, MHCM, FACG, AGAF